These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19520290)
1. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects. Basken NE; Green MA Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290 [TBL] [Abstract][Full Text] [Related]
2. Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals. Basken NE; Mathias CJ; Green MA J Pharm Sci; 2009 Jun; 98(6):2170-9. PubMed ID: 18937368 [TBL] [Abstract][Full Text] [Related]
3. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Basken NE; Mathias CJ; Lipka AE; Green MA Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683 [TBL] [Abstract][Full Text] [Related]
4. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. Mathias CJ; Bergmann SR; Green MA J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593 [TBL] [Abstract][Full Text] [Related]
5. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions. Lim JK; Mathias CJ; Green MA J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338 [TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals. Maurer RI; Blower PJ; Dilworth JR; Reynolds CA; Zheng Y; Mullen GE J Med Chem; 2002 Mar; 45(7):1420-31. PubMed ID: 11906283 [TBL] [Abstract][Full Text] [Related]
7. Impact of human serum albumin on Cu Martínez-Camarena Á; Sour A; Faller P Dalton Trans; 2023 Oct; 52(38):13758-13768. PubMed ID: 37720931 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and formulation of [ Green MA; Mathias CJ Appl Radiat Isot; 2022 Apr; 182():110119. PubMed ID: 35093818 [TBL] [Abstract][Full Text] [Related]
9. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia. Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509 [TBL] [Abstract][Full Text] [Related]
10. Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity. Xiao Z; Donnelly PS; Zimmermann M; Wedd AG Inorg Chem; 2008 May; 47(10):4338-47. PubMed ID: 18412332 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes. Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands. Ackerman LJ; West DX; Mathias CJ; Green MA Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194 [TBL] [Abstract][Full Text] [Related]
13. Release of CuPTSM from human serum albumin after addition of fatty acids. Yuan H; Antholine WE; Subczynski WK; Green MA J Inorg Biochem; 1996 Mar; 61(4):251-9. PubMed ID: 8867452 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrest in cultured neuroblastoma cells exposed to a bis(thiosemicarbazonato) metal complex. Bica L; Meyerowitz J; Parker SJ; Caragounis A; Du T; Paterson BM; Barnham KJ; Crouch PJ; White AR; Donnelly PS Biometals; 2011 Feb; 24(1):117-33. PubMed ID: 20931265 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives. John EK; Green MA J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070 [TBL] [Abstract][Full Text] [Related]
16. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization. Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599 [TBL] [Abstract][Full Text] [Related]
17. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding. Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136 [TBL] [Abstract][Full Text] [Related]
18. Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)-amino acid] and [Cu(ATSM)-octreotide] conjugates. Cowley AR; Dilworth JR; Donnelly PS; Heslop JM; Ratcliffe SJ Dalton Trans; 2007 Jan; (2):209-17. PubMed ID: 17180189 [TBL] [Abstract][Full Text] [Related]
19. Peculiar reactivity of a di-imine copper(II) complex regarding its binding to albumin protein. Silveira VC; Abbott MP; Cavicchioli M; Gonçalves MB; Petrilli HM; de Rezende L; Amaral AT; Fonseca DE; Caramori GF; Ferreira AM Dalton Trans; 2013 May; 42(18):6386-96. PubMed ID: 23462863 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]